Again, a more detailed analysis in appropriate preclinical models is needed to provide the proof of concept that inhibition of the EGFR-MEK pathway has an impact on CNI and resembles an effective treatment for SChigh HNSCC. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.